Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


07.11.2022

3 Am J Med
2 Antiviral Res
1 BMC Pediatr
4 BMJ
2 Epidemiol Infect
7 Eur J Epidemiol
1 J Gen Virol
10 J Infect Dis
2 J Virol
2 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
9 Pediatrics
2 PLoS Med
49 PLoS One
4 Proc Natl Acad Sci U S A
2 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. GOETZL EJ, Kapogiannis D
    Long-COVID: Phase 2 of the COVID-19 Pandemic.
    Am J Med. 2022;135:1277-1279.
    PubMed        

  2. HERNANDEZ AV, Piscoya A, Pasupuleti V, Phan MT, et al
    Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis.
    Am J Med. 2022;135:1349-1361.
    PubMed         Abstract available

  3. ARENA R, Pronk NP, Laddu D, Whitsel LP, et al
    Mapping One Million COVID-19 Deaths and Unhealthy Lifestyle Behaviors in the United States: Recognizing the Syndemic Pattern and Taking Action.
    Am J Med. 2022;135:1288-1295.
    PubMed         Abstract available


    Antiviral Res

  4. PATEL MC, Flanigan D, Feng C, Chesnokov A, et al
    An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance.
    Antiviral Res. 2022 Nov 1:105457. doi: 10.1016/j.antiviral.2022.105457.
    PubMed         Abstract available

  5. PASCUA PNQ, Jones JC, Webby RJ, Govorkova EA, et al
    Effect of E23G/K, F36V, N37T, E119D, and E199G polymerase acidic protein substitutions on the replication and baloxavir susceptibility of influenza B viruses.
    Antiviral Res. 2022 Oct 31:105455. doi: 10.1016/j.antiviral.2022.105455.
    PubMed         Abstract available


    BMC Pediatr

  6. CHOI H, Lee EJ, Ahn YS, Yoo YM, et al
    Effects of the Omicron variant on perinatal outcomes in full-term neonates.
    BMC Pediatr. 2022;22:625.
    PubMed         Abstract available


    BMJ

  7. MAHASE E
    Covid-19: Asian patients experienced largest fall in elective care, report finds.
    BMJ. 2022;379:o2644.
    PubMed        

  8. WARD T, Christie R, Paton RS, Cumming F, et al
    Transmission dynamics of monkeypox in the United Kingdom: contact tracing study.
    BMJ. 2022;379:e073153.
    PubMed         Abstract available

  9. DYER C
    Oncologist who attended surgery on two patients while he had covid is suspended for three months.
    BMJ. 2022;379:o2624.
    PubMed        

  10. LOOI MK, Mahase E
    Has covid-19 become milder?
    BMJ. 2022;379:o2516.
    PubMed        


    Epidemiol Infect

  11. LIM WW, Cowling BJ, Nakafero G, Feng S, et al
    The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom.
    Epidemiol Infect. 2022 Nov 4:1-30. doi: 10.1017/S0950268822001753.
    PubMed        

  12. MUGHINI-GRAS L, Chaname Pinedo L, Pijnacker R, van den Beld M, et al
    Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
    Epidemiol Infect. 2021;149:e254.
    PubMed         Abstract available


    Eur J Epidemiol

  13. SAMUEL A
    Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2022;37:1083-1084.
    PubMed        

  14. BERGHOFER A, Rotter G, Pankert J, Icke K, et al
    SARS-CoV-2 infections in professional orchestra and choir musicians-a prospective cohort study.
    Eur J Epidemiol. 2022;37:1061-1070.
    PubMed         Abstract available

  15. BANHOLZER N, Lison A, Ozcelik D, Stadler T, et al
    The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review.
    Eur J Epidemiol. 2022;37:1003-1024.
    PubMed         Abstract available

  16. MATHIEU C, Pambrun E, Benard-Laribiere A, Noize P, et al
    Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
    Eur J Epidemiol. 2022;37:1049-1059.
    PubMed         Abstract available

  17. EBELING M, Acosta E, Caswell H, Meyer AC, et al
    Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care.
    Eur J Epidemiol. 2022;37:1025-1034.
    PubMed         Abstract available

  18. BUCYIBARUTA G, Blangiardo M, Konstantinoudis G
    Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
    Eur J Epidemiol. 2022;37:1071-1081.
    PubMed         Abstract available

  19. MCDONALD SA, Lagerweij GR, de Boer P, de Melker HE, et al
    The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
    Eur J Epidemiol. 2022;37:1035-1047.
    PubMed         Abstract available


    J Gen Virol

  20. ROY T, Sharma K, Dhall A, Patiyal S, et al
    In silico method for predicting infectious strains of influenza A virus from its genome and protein sequences.
    J Gen Virol. 2022;103.
    PubMed         Abstract available


    J Infect Dis

  21. GREBE E, Yu EA, Bravo MD, Welte A, et al
    COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors.
    J Infect Dis. 2022 Aug 3. pii: 6654836. doi: 10.1093.
    PubMed         Abstract available

  22. VERKERKE HP, Damhorst GL, Graciaa DS, McLendon K, et al
    Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection.
    J Infect Dis. 2022;226:1577-1587.
    PubMed         Abstract available

  23. ZHANG Y, Gao J, Huang K, Zhao Y, et al
    SARS-CoV-2 Infection Causes Hyperglycemia in Cats.
    J Infect Dis. 2022;226:1568-1576.
    PubMed         Abstract available

  24. SHIH PY, Chou YH, Wei JC
    The Potential Confounders Hiding in a United States Cohort About Severe Acute Respiratory Syndrome Coronavirus 2 Infection During Pregnancy.
    J Infect Dis. 2022;226:1678.
    PubMed        

  25. ARAH OA, Sullivan SG, Fell DB, Regan AK, et al
    Analyzing Uncontrolled Confounding of the Perinatal Health Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection During Pregnancy.
    J Infect Dis. 2022;226:1678-1680.
    PubMed        

  26. MEISTER TL, Dreismeier M, Blanco EV, Bruggemann Y, et al
    Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients.
    J Infect Dis. 2022;226:1608-1615.
    PubMed         Abstract available

  27. KUO TY, Lien CE, Lin YJ, Lin MY, et al
    Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.
    J Infect Dis. 2022;226:1562-1567.
    PubMed         Abstract available

  28. BEDDINGFIELD BJ, Rowe LA, Russell-Lodrigue KE, Doyle-Meyers LA, et al
    Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis.
    J Infect Dis. 2022;226:1588-1592.
    PubMed         Abstract available

  29. CHEN C, Haupert SR, Zimmermann L, Shi X, et al
    Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.
    J Infect Dis. 2022;226:1593-1607.
    PubMed         Abstract available

  30. ZHU KL, Gao HX, Yao L, Rong J, et al
    Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron.
    J Infect Dis. 2022 Apr 16. pii: 6569353. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  31. CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
    Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
    PubMed         Abstract available

  32. MO JS, Abente EJ, Cardenas Perez M, Sutton TC, et al
    Transmission of Human Influenza A Virus in Pigs Selects for Adaptive Mutations on the HA Gene.
    J Virol. 2022 Nov 1:e0148022. doi: 10.1128/jvi.01480.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  33. SULLIVAN M, Perrine CG, Kelleher J, Kanwar O, et al
    Notes From the Field: Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-August 28, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1384-1385.
    PubMed         Abstract available

  34. BOEHMER TK, Koumans EH, Skillen EL, Kappelman MD, et al
    Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 - United States, January-July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1359-1365.
    PubMed         Abstract available


    N Engl J Med

  35. RUBIN EJ, Baden LR, Hardin CC, Morrissey S, et al
    Audio Interview: Caring for Hospitalized Patients with Covid-19.
    N Engl J Med. 2022;387:e51.
    PubMed        

  36. EMANUEL EJ, Upshur REG, Smith MJ
    What Covid Has Taught the World about Ethics.
    N Engl J Med. 2022;387:1542-1545.
    PubMed        

  37. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
    N Engl J Med. 2022;387:e50.
    PubMed        

  38. ANDERSON EJ, Creech CB, Berthaud V, Piramzadian A, et al
    Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
    N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMoa2209367.
    PubMed         Abstract available

  39. CHEMAITELLY H, Ayoub HH, Tang P, Hasan MR, et al
    Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
    N Engl J Med. 2022 Oct 12. doi: 10.1056/NEJMc2211055.
    PubMed        

  40. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Hasan MR, et al
    Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMc2209306.
    PubMed        


    Pediatrics

  41. CAPRETTI MG, Marsico C, Gabrielli L, Vocale C, et al
    Infants Born Following SARS-CoV-2 Infection in Pregnancy.
    Pediatrics. 2022 Oct 26. pii: 189773. doi: 10.1542/peds.2022-056206.
    PubMed         Abstract available

  42. MCCLAFFERTY HH, Hubbard DK, Foradori D, Brown ML, et al
    Physician Health and Wellness.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  43. MATTISON CP, Calderwood LE, Marsh ZA, Wikswo ME, et al
    Childcare and School Acute Gastroenteritis Outbreaks: 2009-2020.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  44. CORRADO A, Yoshiba G, Buranosky M, Woods Z, et al
    A 43-Day-Old Male With Respiratory Distress and Acute-Onset Hypotonia.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  45. ROSENBERG J, Rosenthal A, Castillo S, Edwards E, et al
    Medical Certification for Utility Shut-Off Protection and Health-Related Social Needs.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  46. CAMPBELL MM, Benjamin DK, Mann TK, Fist A, et al
    Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 Schools.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  47. STICH M, Benning L, Speer C, Garbade SF, et al
    Waning Immunity 14 Months After SARS-CoV-2 Infection.
    Pediatrics. 2022;150.
    PubMed        

  48. ANTOON JW, Hall M, Howard LM, Herndon A, et al
    COVID-19 and Acute Neurologic Complications in Children.
    Pediatrics. 2022;150.
    PubMed         Abstract available

  49. AMODIO E, Genovese D, Mazzeo L, Martino L, et al
    Effectiveness of mRNA COVID-19 Vaccines in Adolescents Over 6 Months.
    Pediatrics. 2022 Aug 10. pii: 188742. doi: 10.1542/peds.2022-057394.
    PubMed         Abstract available


    PLoS Med

  50. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2022;19:e1003979.
    PubMed         Abstract available

  51. LOWE DM, Brown LK, Chowdhury K, Davey S, et al
    Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
    PLoS Med. 2022;19:e1004120.
    PubMed         Abstract available


    PLoS One

  52. RAGHOEBAR S, Delnoij J, Kamphorst BA, Broekhuizen H, et al
    Exposure to images showing (non)adherence to physical distancing rules: Effect on adherence behavior and perceived social norms.
    PLoS One. 2022;17:e0276936.
    PubMed         Abstract available

  53. GETACHEW D, Yosef T, Solomon N, Tesfaye M, et al
    Predictors of unwillingness to receive COVID -19 vaccines among Ethiopian Medical students.
    PLoS One. 2022;17:e0276857.
    PubMed         Abstract available

  54. BALDI ME, Laghrissi A, Marso Z, Chellat FZ, et al
    Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study.
    PLoS One. 2022;17:e0277157.
    PubMed         Abstract available

  55. KIRCHNER T, Heinrich S, Bonifacius A, Engel B, et al
    Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
    PLoS One. 2022;17:e0276929.
    PubMed         Abstract available

  56. LUCACI AG, Zehr JD, Shank SD, Bouvier D, et al
    RASCL: Rapid Assessment of Selection in CLades through molecular sequence analysis.
    PLoS One. 2022;17:e0275623.
    PubMed         Abstract available

  57. GANESAN S, Acosta H, Brigolin C, Orange K, et al
    Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
    PLoS One. 2022;17:e0272594.
    PubMed         Abstract available

  58. SCHERBOV S, Gietel-Basten S, Ediev D, Shulgin S, et al
    COVID-19 and excess mortality in Russia: Regional estimates of life expectancy losses in 2020 and excess deaths in 2021.
    PLoS One. 2022;17:e0275967.
    PubMed         Abstract available

  59. HEGAZI MA, Butt NS, Sayed MH, Zubairi NA, et al
    Evaluation of the virtual learning environment by school students and their parents in Saudi Arabia during the COVID-19 pandemic after school closure.
    PLoS One. 2022;17:e0275397.
    PubMed         Abstract available

  60. WHITEHEAD IO, Moffatt S, Jagger C, Hanratty B, et al
    A national study of burnout and spiritual health in UK general practitioners during the COVID-19 pandemic.
    PLoS One. 2022;17:e0276739.
    PubMed         Abstract available

  61. MARSH AA, Magalhaes M, Peeler M, Rose SM, et al
    Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials.
    PLoS One. 2022;17:e0275823.
    PubMed         Abstract available

  62. BLANCHFLOWER DG, Bryson A
    Chronic pain: Evidence from the national child development study.
    PLoS One. 2022;17:e0275095.
    PubMed         Abstract available

  63. LIU D, Kwan MP
    Integrated analysis of doubly disadvantaged neighborhoods by considering both green space and blue space accessibility and COVID-19 infection risk.
    PLoS One. 2022;17:e0273125.
    PubMed         Abstract available

  64. HARTZ DL, Tracy SK, Pairman S, Yates A, et al
    Midwives speaking out on COVID-19: The international confederation of midwives global survey.
    PLoS One. 2022;17:e0276459.
    PubMed         Abstract available

  65. SYLVERKEN AA, Owusu M, Agbavor B, Kwarteng A, et al
    Using drones to transport suspected COVID-19 samples; experiences from the second largest testing centre in Ghana, West Africa.
    PLoS One. 2022;17:e0277057.
    PubMed         Abstract available

  66. SUTTON NR, Robinson-Lane SG, Yeow RY, Chubb HA, et al
    Racial and ethnic variation in COVID-19 care, treatment, and outcomes: A retrospective cohort study from the MiCOVID-19 registry.
    PLoS One. 2022;17:e0276806.
    PubMed         Abstract available

  67. URUMA Y, Manabe T, Fujikura Y, Iikura M, et al
    Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276774.
    PubMed         Abstract available

  68. KIM HW, Hong JW, Nam EJ, Kim KY, et al
    Medical students' perceived stress and perceptions regarding clinical clerkship during the COVID-19 pandemic.
    PLoS One. 2022;17:e0277059.
    PubMed         Abstract available

  69. BARRETO APA, Barreto Filho MA, Duarte LC, Cerqueira-Silva T, et al
    Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis.
    PLoS One. 2022;17:e0276771.
    PubMed         Abstract available

  70. HOMAYUNI A, Hosseini Z, Shahabi N, Ezati Rad R, et al
    Quality of life and its related psychological problems during coronavirus pandemic.
    PLoS One. 2022;17:e0276841.
    PubMed         Abstract available

  71. LYU T, Liang C, Liu J, Campbell B, et al
    Temporal Events Detector for Pregnancy Care (TED-PC): A rule-based algorithm to infer gestational age and delivery date from electronic health records of pregnant women with and without COVID-19.
    PLoS One. 2022;17:e0276923.
    PubMed         Abstract available

  72. YAGLOM HD, Maurer M, Collins B, Hojnacki J, et al
    One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021.
    PLoS One. 2022;17:e0272830.
    PubMed         Abstract available

  73. SWED S, Kashkash F, Shoib S, Shaheen N, et al
    Anxiety and depression among patient's companions during admission to the ICU in the Omicron wave of COVID-19: A cross-sectional study in Aleppo University Hospital.
    PLoS One. 2022;17:e0273900.
    PubMed         Abstract available

  74. ALDALLAL R, Gemeay AM, Hussam E, Kilai M, et al
    Statistical modeling for COVID 19 infected patient's data in Kingdom of Saudi Arabia.
    PLoS One. 2022;17:e0276688.
    PubMed         Abstract available

  75. TSUBOI K, Fujiwara N, Itoh R
    Influence of trip distance and population density on intra-city mobility patterns in Tokyo during COVID-19 pandemic.
    PLoS One. 2022;17:e0276741.
    PubMed         Abstract available

  76. DALY LYNN J, Ramsey L, Marley J, Rohde J, et al
    Participatory peer research exploring the experience of learning during Covid-19 for allied health and healthcare science students.
    PLoS One. 2022;17:e0276180.
    PubMed         Abstract available

  77. ESPINOZA MA, Bilbeny N, Abbott T, Carcamo C, et al
    Cost analysis of chronic pain due to musculoskeletal disorders in Chile.
    PLoS One. 2022;17:e0273667.
    PubMed         Abstract available

  78. CONTRACTOR A, Shivaprakash S, Tiwari A, Setia MS, et al
    Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: A retrospective cohort analysis.
    PLoS One. 2022;17:e0276759.
    PubMed         Abstract available

  79. YOSHIKAWA A, Tashiro N, Ohtsuka H, Aoki K, et al
    Protocol for educational programs on infection prevention/control for medical and healthcare student: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276851.
    PubMed         Abstract available

  80. MELO G, Monteza D, Colson G, Zhang YY, et al
    How to assess? Student preferences for methods to assess experiential learning: A best-worst scaling approach.
    PLoS One. 2022;17:e0276745.
    PubMed         Abstract available

  81. OMRI N, Ezzi O, Ammar A, Benzarti W, et al
    Compassion fatigue among frontline healthcare workers during the covid-19 pandemic in Tunisia.
    PLoS One. 2022;17:e0276455.
    PubMed         Abstract available

  82. SCHROEDER AR, Dahlen A, Purington N, Alvarez F, et al
    Healthcare utilization in children across the care continuum during the COVID-19 pandemic.
    PLoS One. 2022;17:e0276461.
    PubMed         Abstract available

  83. KNICKERBOCKER KJ, Cox EA, Dhawka L, Woods K, et al
    Intra-individual impact of the COVID-19 pandemic on mental health and sleep in young adults.
    PLoS One. 2022;17:e0276165.
    PubMed         Abstract available

  84. WONG JJM, Abbas Q, Liauw F, Malisie RF, et al
    Development and validation of a clinical predictive model for severe and critical pediatric COVID-19 infection.
    PLoS One. 2022;17:e0275761.
    PubMed         Abstract available

  85. ARUFFO E, Yuan P, Tan Y, Gatov E, et al
    Community structured model for vaccine strategies to control COVID19 spread: A mathematical study.
    PLoS One. 2022;17:e0258648.
    PubMed         Abstract available

  86. MAINA D, Omuse G, Ong'ete G, Mugaine P, et al
    Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    PLoS One. 2022;17:e0267619.
    PubMed         Abstract available

  87. CAO K, Deng T, Zhang C, Lu L, et al
    A CNN-transformer fusion network for COVID-19 CXR image classification.
    PLoS One. 2022;17:e0276758.
    PubMed         Abstract available

  88. ODACHI R, Takahashi S, Sugawara D, Tabata M, et al
    The Big Five personality traits and the fear of COVID-19 in predicting depression and anxiety among Japanese nurses caring for COVID-19 patients: A cross-sectional study in Wakayama prefecture.
    PLoS One. 2022;17:e0276803.
    PubMed         Abstract available

  89. CINGEL DP, Lauricella AR, Taylor LB, Stevens HR, et al
    U.S. adolescents' attitudes toward school, social connection, media use, and mental health during the COVID-19 pandemic: Differences as a function of gender identity and school context.
    PLoS One. 2022;17:e0276737.
    PubMed         Abstract available

  90. SOHAL KS, Moris RL, Moshy JR
    Knowledge, attitudes, and practices related to COVID-19 among patients attending public dental clinics in Tanzania: A cross-sectional study.
    PLoS One. 2022;17:e0276620.
    PubMed         Abstract available

  91. BUDREVICIUTE A, Raila G, Paukstaitiene R, Valius L, et al
    An analysis of the causes of exhaustion among physicians working in family physician teams during the COVID-19 pandemic in Lithuania.
    PLoS One. 2022;17:e0274360.
    PubMed         Abstract available

  92. DOWTHWAITE L, Wagner HG, Babbage CM, Fischer JE, et al
    The relationship between trust and attitudes towards the COVID-19 digital contact-tracing app in the UK.
    PLoS One. 2022;17:e0276661.
    PubMed         Abstract available

  93. CHAMBON M, Dalege J, Waldorp LJ, Van der Maas HLJ, et al
    Tailored interventions into broad attitude networks towards the COVID-19 pandemic.
    PLoS One. 2022;17:e0276439.
    PubMed         Abstract available

  94. COMAN C, Bularca MC, Repanovici A, Rogozea L, et al
    Misinformation about medication during the COVID- 19 pandemic: A perspective of medical staff.
    PLoS One. 2022;17:e0276693.
    PubMed         Abstract available

  95. MALIK A, Toth EN, Teng MS, Hurst J, et al
    Distorted TCR repertoires define multisystem inflammatory syndrome in children.
    PLoS One. 2022;17:e0274289.
    PubMed         Abstract available

  96. FAROOQ M, Ijaz M, Atif M, Abushal T, et al
    Statistical analysis of Covid-19 mortality rate via probability distributions.
    PLoS One. 2022;17:e0274133.
    PubMed         Abstract available

  97. CHAMIE G, Prado P, Oviedo Y, Vizcaino T, et al
    Reproducibility and implementation of a rapid, community-based COVID-19 "test and respond" model in low-income, majority-Latino communities in Northern California.
    PLoS One. 2022;17:e0276257.
    PubMed         Abstract available

  98. VAN BEEK J, Teesing G, Oude Munnink BB, Meima A, et al
    Population-based screening in a municipality after a primary school outbreak of the SARS-CoV-2 Alpha variant, the Netherlands, December 2020-February 2021.
    PLoS One. 2022;17:e0276696.
    PubMed         Abstract available

  99. TOBOLOWSKY FA, Waltenburg MA, Moritz ED, Haile M, et al
    Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020April 2021.
    PLoS One. 2022;17:e0275718.
    PubMed         Abstract available

  100. ASARE BY, Thomas E, Affandi JS, Schammer M, et al
    Multiple health-related behaviours among Fly-In Fly-Out workers in the mining industry in Australia: A cross-sectional survey during the COVID-19 pandemic.
    PLoS One. 2022;17:e0275008.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  101. LIU Q, Miao H, Li S, Zhang P, et al
    Anti-PF4 antibodies associated with disease severity in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2213361119.
    PubMed         Abstract available

  102. MCMAHON M, O'Dell G, Tan J, Sarkozy A, et al
    Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2206333119.
    PubMed         Abstract available

  103. HARRISON NL, Sachs JD
    Reply to Garry: The origin of SARS-CoV-2 remains unresolved.
    Proc Natl Acad Sci U S A. 2022;119:e2215826119.
    PubMed        

  104. ZHANG P, Philippot Q, Ren W, Lei WT, et al
    Genome-wide detection of human variants that disrupt intronic branchpoints.
    Proc Natl Acad Sci U S A. 2022;119:e2211194119.
    PubMed         Abstract available


    Vaccine

  105. KUNASEKARAN M, Moa A, Hooshmand E, Trent M, et al
    Effectiveness estimates for enhanced trivalent influenza vaccines in an aged care summer outbreak.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)00766.
    PubMed         Abstract available

  106. KUNASEKARAN M, Poulos CJ, Chughtai AA, Heslop DJ, et al
    Factors associated with repeated influenza vaccine uptake among aged care staff in an Australian sample from 2017 to 2019.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)00981.
    PubMed         Abstract available


    Virus Res

  107. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: